So, your startup wants to play in Japan’s Regulatory Sandbox?

Disruption comes slowly to medicine.  And that's a good thing. 

Since the ethos of the profession is "First, do no harm", it makes sense that safety and efficacy are prioritized over rapid innovation. 

But innovation does happen, and the Japanese government is working to make sure it happens faster. Today we sit down with Taro Ueno of Susmed and talk about the challenges and tradeoffs in innovative medicine. 

We talk about why he left medical research for entrepreneurship, and how iPhone apps and blockchain are being used clinically in Japan. And in both cases, I assure you,. it's not what you think.

It's a great conversation, and I think you'll enjoy it.